论文部分内容阅读
目的：分析克拉霉素联合三联疗法治疗幽门螺旋杆菌（Hp）感染相关胃炎的临床效果。方法对116例幽门螺旋杆菌感染相关胃炎进行研究，随机分为观察组58例、对照组58例，对比两组症状评分变化情况、总有效率及Hp根除率。结果治疗后，观察组消化道症状评分低于对照组，差异显著（P<0.05）。观察组、对照组总有效率分别为94.83%、82.76%，Hp根除率分别为96.55%、84.48%，差异显著（P<0.05）。结论克拉霉素联合三联疗法治疗幽门螺旋杆菌感染相关胃炎的临床效果显著，临床价值高。“,”ObjectiveTo analyze the clinical effect of clarithromycin combined with triple therapy on Helicobacter pylori (Hp) infection associated gastritis. Methods116 cases of gastritis associated with Helicobacter pylori infection were randomly divided into observation group (58 cases) and control group (58 cases). The change of symptom score, total effective rate and eradication rate of Hp were compared between the two groups.ResultsAfter treatment, the digestiv e tract symptom score of the observation group was lower than that of the control group (P <0.05). The total effective rate of the observation group and the control group were 94.83% and 82.76%, respectively, and the eradication rates of Hp were 96.55% and 84.48%, respectively (P<0.05).Conclusion Clarithromycin combined with triple therapy in the treatment of Helicobacter pylori infection associated with gastritis clinical effect is significant, to promote high value.